Skip to main content

Covariate Distribution Models in Simulation

  • Chapter
  • First Online:
Book cover Clinical Trial Simulations

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 1))

  • 2558 Accesses

Abstract

The components of a clinical trial simulation consist of the input–output model, the covariate distribution model, and the trial execution model. The input–output model consists of submodels that incorporate the drug’s pharmacokinetics and pharmacodynamics, the disease progression during the trial, the trial endpoints, and the residual variability. Some of these submodels may include covariate influences on model parameters, which comprise the covariate distribution model. Appropriate simulation of clinical trials requires appropriate simulation of covariates because generation of covariates from an invalid probability distribution may result in an inadequate distribution of the simulation output. Basically, you need the right inputs to get the right outputs. This chapter will define covariate distribution models, will show how internal and external datasets may be used to define an appropriate probability distribution, and will demonstrate how to model covariate distributions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aarons L, Vozeh S, Wenk M, Weiss P, Follath F (1989) Population pharmacokinetics of tobramycin. Br J Clin Pharmacol 38:305–314

    Article  Google Scholar 

  • Bonate PL (2006) Pharmacokinetic-pharmacodynamic modeling and simulation. Springer, New York

    Google Scholar 

  • Chien JY, Friedrich S, Heathman M, de Alwis DP, Sinha V (2005) Pharmacokinetics/pharmacodynamics and the stages of development: role of modeling and simulation. AAPS J 7:E544–E559

    Article  PubMed  Google Scholar 

  • Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41

    Article  PubMed  CAS  Google Scholar 

  • Holford NHG, Kimko HC, Monteleone JPR, Peck CC (2000) Simulation of clinical trials. Annu Rev Pharmacol Toxicol 40:209–234

    Article  PubMed  CAS  Google Scholar 

  • Kirk RE (1982) Experimental design: procedures for the behavioral sciences. Brooks/Cole Publishing Company, Belmont

    Google Scholar 

  • Lazo M, Selvin E, Clark JM (2008) Clinical implications of short-term variability in liver function test results. Ann Intern Med 148:348–352

    Article  PubMed  Google Scholar 

  • Lowe PJ, Tannenbaum S, Gautier A, Jimenez P (2009) Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics, and symptoms in patients with severe allergic (IgE-mediated) asthma. Br J Clin Pharmacol 68:61–76

    Article  PubMed  CAS  Google Scholar 

  • Metropolis N (1987) The beginning of the Monte Carlo method. Los Alamos Sci 12:125–130

    Google Scholar 

  • Savage S (2009) The flaw of averages. Wiley, New York

    Google Scholar 

  • U.S. Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Health Statistics (2007) National health and nutrition examination survey, 2007–2008. http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/overviewbrochure_0708.pdf. Accessed May 2010

  • Yohai VJ (1987) High breakdown point and high efficiency robust estimates for regression. Ann Statist 16:642–656

    Article  Google Scholar 

Download references

Acknowledgments

The author would like to thank Steve Weller at GlaxoSmithKline for his thoughtful comments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter L. Bonate .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bonate, P.L. (2011). Covariate Distribution Models in Simulation. In: Kimko, H., Peck, C. (eds) Clinical Trial Simulations. AAPS Advances in the Pharmaceutical Sciences Series, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7415-0_22

Download citation

Publish with us

Policies and ethics